FDA Greenlights Cancer Drug From China Amid Shortage | China In Focus

FDA Greenlights Cancer Drug From China Amid Shortage | China In Focus​

Cancer #drugs are in short supply, and this problem is now gripping American health care. To help, the Food and Drug Administration (#FDA) is greenlighting a cancer drug from China. Some applaud the decision, while others warn that Beijing could use medicines as a weapon against the United States by withholding supplies or selling drugs that lack effective ingredients.